Could these two small-cap growth champions make you a million?

With earnings growing rapidly, these two small-caps are on track to produce enormous returns for investors.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Eckoh (LSE: ECK) is not your typical growth stock. After a successful 2013 and 2014, the company floundered for two years before finally waking up at the beginning of this year. 

Year-to-date shares in the company have gained 40% thanks to improved trading, and it looks as if this is set to continue. According to a trading update from the firm today, for the six months to the end of September, the group achieved double-digit percentage year-on-year growth in both revenue and gross profit. 

In the UK, trading is going to plan with revenue coming in at a similar level to the same period last year. Heading into the second half, management reports that the firm has a robust pipeline of deals in progress. Over in the US, where management has been concentrating on growth, the push is going well with seven contract wins worth $5.1m secured during the half year, up from three wins worth $2.7m the year before. 

Since 2014 when Eckoh entered the US market, the firm has won 30 contracts and growth is picking up. The company has secured the same volume of contracts during the past six months as were won during the full 12-month period ending 31 March 2017.

Global leader 

Eckoh is a global provider of secure payment products and customer contact solutions, which include the group’s patented CallGuard software that can be deployed on a client’s site to remove sensitive personal and payment data from contact centres. The company is capitalising on the shift away from brick & mortar stores towards an online shopping experience as consumers seek more for less. And as this market expands, City analysts are expecting big things from the firm. 

Indeed, the they are forecasting earnings per share growth of 172% for the fiscal year ending 31 March 2018, followed by growth of 16% for the following financial year. Looking at today’s trading update, it would appear that the company is on track to hit these targets. Even though the shares look pricey, trading at a forward P/E of 31.5, considering Eckoh’s explosive growth rate, I believe investors will be able to pocket a healthy profit even buying at this level. 

Exceptional level of demand 

Another top growth champion is Microgen (LSE: MCGN). Over the past year, its shares have risen 140% as demand for the company’s services has exploded. 

The tech company reported earnings growth of 28% and 34% for 2015 and 2016, respectively. It looks as if the group is on track to report a similar performance this year. At the beginning of July, management reported that there had been an “exceptional level of demand” for its Aptitude Software, which is designed for the financial services industry. 

I believe that as regulators demand more of financial firms, all of which are trying to keep costs low, companies like Microgen will benefit as software takes the place of humans. And the City seems to agree. Analysts are projecting earnings per share growth of 24% for 2017 and 20% for 2018 justifying the high valuation of 28.7 times forward earnings. But considering the high level of demand for the latest products, I believe that the firm could smash City expectations for this year, which would mean that this valuation is out of date. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Here’s how someone could start investing in 2025 with just £1,000

Planning to start investing in 2025? This writer highlights two very different stocks that might be worth considering for a…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

I asked ChatGPT which UK stocks Warren Buffett might look to buy. It suggested these 5 names

ChatGPT has some ideas about FTSE 100 stocks Warren Buffett might have been buying. But Stephen Wright thinks a closer…

Read more »

Investing Articles

Up 14% today! Here’s one growth stock that Elon Musk likes

A UK growth stock has signed another contract with SpaceX. But does this mean it deserves a place in my…

Read more »

Investing Articles

I asked ChatGPT if the FTSE 100 would hit 10,000 this year. It’s feeling bullish!

The FTSE 100's flying and Harvey Jones is feeling bullish. His obvious next step was to ask a chatbot where…

Read more »

Investing Articles

Near 52-week lows, are these FTSE 100 stocks now unmissable bargains?

Two FTSE 100 titans just can't stop falling in value. Paul Summers looks at whether investors should see this as…

Read more »

Investing Articles

Bill Ackman just loaded up on this top stock for his FTSE 100-listed fund

The well-known hedge fund manager has announced a massive holding in this tech stock for his FTSE 100-listed investment trust.

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Billionaire Bill Ackman has just made a huge bet on this S&P 500 growth stock

Bill Ackman just bought 30m shares in this well-known S&P 500 company. He believes it’s currently trading well below its…

Read more »

Investing Articles

40 and no pension? Here’s what £400 a month in a Stocks and Shares ISA could become

It's never too late to start investing for retirement. Here's how regular contributions to a Stocks and Shares ISA could…

Read more »